News Column

New Gene Therapy Data Have Been Reported by Investigators at Institute of Neuroscience

June 5, 2014



By a News Reporter-Staff News Editor at Gene Therapy Weekly -- A new study on Biotechnology is now available. According to news originating from Cagliari, Italy, by NewsRx correspondents, research stated, "Neuroactive steroids are endogenous neuromodulators capable of altering neuronal activity and behavior. In rodents, systemic administration of endogenous or synthetic neuroactive steroids reduces ethanol self-administration."

Our news journalists obtained a quote from the research from the Institute of Neuroscience, "We hypothesized this effect arises from actions within mesolimbic brain regions that we targeted by viral gene delivery. Cytochrome P450 side chain cleavage (P450scc) converts cholesterol to pregnenolone, the rate-limiting enzymatic reaction in neurosteroidogenesis. Therefore, we constructed a recombinant adeno-associated serotype 2 viral vector (rAAV2), which drives P450scc expression and neuroactive steroid synthesis. The P450scc-expressing vector (rAAV2-P450scc) or control GFP-expressing vector (rAAV2-GFP) were injected bilaterally into the ventral tegmental area (VTA) or nucleus accumbens (NAc) of alcohol preferring (P) rats trained to self-administer ethanol. P450scc overexpression in the VTA significantly reduced ethanol self-administration by 20% over the 3 week test period. P450scc overexpression in the NAc, however, did not alter ethanol self-administration. Locomotor activity was unaltered by vector administration to either region. P450scc overexpression produced a 36% increase in (3 alpha,5 alpha)-3-hydroxypregnan-20-one (3 alpha,5 alpha-THP, allopregnanolone)-positive cells in the VTA, but did not increase 3 alpha,5 alpha-THP immunoreactivity in NAc. These results suggest that P450scc overexpression and the resultant increase of 3 alpha,5 alpha-THP-positive cells in the VTA reduces ethanol reinforcement. 3 alpha,5 alpha-THP is localized to neurons in the VTA, including tyrosine hydroxylase neurons, but not astrocytes."

According to the news editors, the research concluded: "Overall, the results demonstrate that using gene delivery to modulate neuroactive steroids shows promise for examining the neuronal mechanisms of moderate ethanol drinking, which could be extended to other behavioral paradigms and neuropsychiatric pathology."

For more information on this research see: Overexpression of the Steroidogenic Enzyme Cytochrome P450 Side Chain Cleavage in the Ventral Tegmental Area Increases 3 alpha,5 alpha-THP and Reduces Long-Term Operant Ethanol Self-Administration. Journal of Neuroscience, 2014;34(17):5824-5834. Journal of Neuroscience can be contacted at: Soc Neuroscience, 11 Dupont Circle, NW, Ste 500, Washington, DC 20036, USA. (Society for Neuroscience - www.sfn.org/; Journal of Neuroscience - www.sfn.org/index.aspx?pagename=JournalOfNeuroscience)

The news correspondents report that additional information may be obtained from J.B. Cook, Natl Res Council Italy, Inst Neurosci, I-09129 Cagliari, Italy. Additional authors for this research include D.F. Werner, A.M. Maldonado-Devincci, M.N. Leonard, K.R. Fisher, T.K. O'Buckley, P. Porcu, T.J. McCown, J. Besheer, C.W. Hodge and A.L. Morrow (see also Biotechnology).

Keywords for this news article include: Biotechnology, Italy, Europe, Cagliari, Alcohols, Brain Stem, Cytochromes, Gene Therapy, Hemeproteins, Ethanolamines, Bioengineering, Central Nervous System, Tegmentum Mesencephali, Ventral Tegmental Area

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Gene Therapy Weekly


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters